BioCentury
ARTICLE | Clinical News

Heparin regulatory update

March 24, 2008 7:00 AM UTC

Baxter and FDA said they have identified the contaminant found in the active pharmaceutical ingredient (API) used in the company's heparin vial products. The contaminant is hypersulfated chondroitin s...